Nervgen Pharma Corp Stock Price History

Stocks . Canada . 
Stock . NervGen Pharma Corp
NGEN Stock  CAD 3.00  0.13  4.15%   
Below is the normalized historical share price chart for NervGen Pharma Corp extending back to March 15, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of NervGen Pharma stands at 3.00, as last reported on the 23rd of December, with the highest price reaching 3.10 and the lowest price hitting 2.77 during the day.
200 Day MA
2.506
50 Day MA
2.5492
Beta
1.351
 
Covid
If you're considering investing in NervGen Stock, it is important to understand the factors that can impact its price. NervGen Pharma appears to be dangerous, given 3 months investment horizon. NervGen Pharma Corp has Sharpe Ratio of 0.0711, which conveys that the firm had a 0.0711% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for NervGen Pharma, which you can use to evaluate the volatility of the firm. Please exercise NervGen Pharma's Downside Deviation of 5.03, mean deviation of 3.84, and Risk Adjusted Performance of 0.0508 to check out if our risk estimates are consistent with your expectations.
  
At this time, NervGen Pharma's Liabilities And Stockholders Equity is fairly stable compared to the past year. Other Stockholder Equity is likely to climb to about 14.3 M in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 41.5 M in 2024. . Price Earnings Ratio is likely to drop to -7.51 in 2024. Price Book Value Ratio is likely to drop to -83.66 in 2024. NervGen Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0711

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsNGEN
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 5.9
  actual daily
52
52% of assets are less volatile

Expected Return

 0.42
  actual daily
8
92% of assets have higher returns

Risk-Adjusted Return

 0.07
  actual daily
5
95% of assets perform better
Based on monthly moving average NervGen Pharma is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of NervGen Pharma by adding it to a well-diversified portfolio.
Price Book
22.9812
Book Value
(0.03)
Enterprise Value
190 M
Enterprise Value Ebitda
(4.54)
Shares Float
58.2 M

NervGen Pharma Stock Price History Chart

There are several ways to analyze NervGen Stock price data. The simplest method is using a basic NervGen candlestick price chart, which shows NervGen Pharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceDecember 19, 20243.13
Lowest PriceNovember 15, 20242.09

NervGen Pharma December 23, 2024 Stock Price Synopsis

Various analyses of NervGen Pharma's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell NervGen Stock. It can be used to describe the percentage change in the price of NervGen Pharma from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of NervGen Stock.
NervGen Pharma Price Rate Of Daily Change 0.96 
NervGen Pharma Price Daily Balance Of Power(0.39)

NervGen Pharma December 23, 2024 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in NervGen Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use NervGen Pharma intraday prices and daily technical indicators to check the level of noise trading in NervGen Stock and then apply it to test your longer-term investment strategies against NervGen.

NervGen Stock Price History Data

The price series of NervGen Pharma for the period between Tue, Sep 24, 2024 and Mon, Dec 23, 2024 has a statistical range of 1.04 with a coefficient of variation of 8.06. The daily prices for the period are spread out with arithmetic mean of 2.55. The median price for the last 90 days is 2.54.
OpenHighLowCloseVolume
12/23/2024
 3.10  3.10  2.77  3.00 
12/20/2024 3.10  3.10  2.77  3.00  105,523 
12/19/2024 2.47  3.18  2.47  3.13  298,248 
12/18/2024 2.66  2.69  2.44  2.46  77,502 
12/17/2024 2.82  2.83  2.64  2.65  29,225 
12/16/2024 2.77  2.95  2.77  2.84  65,315 
12/13/2024 2.56  2.75  2.56  2.73  88,026 
12/12/2024 2.55  2.60  2.55  2.57  11,397 
12/11/2024 2.64  2.64  2.50  2.52  45,317 
12/10/2024 2.59  2.71  2.59  2.64  45,514 
12/09/2024 2.62  2.68  2.56  2.56  25,087 
12/06/2024 2.73  2.76  2.60  2.62  26,023 
12/05/2024 2.86  2.88  2.72  2.72  21,765 
12/04/2024 2.90  3.02  2.80  2.86  108,895 
12/03/2024 2.87  3.00  2.87  2.88  23,600 
12/02/2024 2.89  2.95  2.86  2.88  31,813 
11/29/2024 2.77  2.89  2.74  2.87  41,489 
11/28/2024 2.82  2.82  2.78  2.79  10,600 
11/27/2024 2.68  2.82  2.64  2.80  69,257 
11/26/2024 2.70  2.74  2.61  2.65  45,192 
11/25/2024 2.73  2.75  2.62  2.68  43,525 
11/22/2024 2.50  2.72  2.50  2.60  50,782 
11/21/2024 2.27  2.54  2.27  2.53  69,000 
11/20/2024 2.26  2.30  2.22  2.24  12,887 
11/19/2024 2.25  2.30  2.21  2.28  19,524 
11/18/2024 2.14  2.40  2.05  2.24  151,354 
11/15/2024 2.20  2.24  2.05  2.09  185,828 
11/14/2024 2.68  2.68  2.15  2.18  111,268 
11/13/2024 2.68  2.80  2.68  2.68  30,302 
11/12/2024 2.67  2.78  2.65  2.72  60,662 
11/11/2024 2.60  2.70  2.60  2.70  7,926 
11/08/2024 2.59  2.63  2.58  2.62  11,561 
11/07/2024 2.52  2.59  2.48  2.59  14,881 
11/06/2024 2.46  2.59  2.46  2.52  33,445 
11/05/2024 2.48  2.50  2.44  2.44  6,900 
11/04/2024 2.55  2.57  2.44  2.48  29,442 
11/01/2024 2.44  2.66  2.44  2.59  65,731 
10/31/2024 2.36  2.44  2.30  2.44  44,815 
10/30/2024 2.38  2.39  2.32  2.36  37,932 
10/29/2024 2.58  2.58  2.37  2.38  49,883 
10/28/2024 2.72  2.72  2.58  2.60  49,400 
10/25/2024 2.41  2.77  2.41  2.72  112,244 
10/24/2024 2.26  2.41  2.25  2.38  45,500 
10/23/2024 2.20  2.28  2.20  2.26  15,100 
10/22/2024 2.32  2.35  2.21  2.21  82,277 
10/21/2024 2.40  2.41  2.32  2.32  17,492 
10/18/2024 2.44  2.51  2.40  2.40  36,381 
10/17/2024 2.44  2.46  2.42  2.44  25,115 
10/16/2024 2.46  2.47  2.40  2.45  19,216 
10/15/2024 2.39  2.49  2.39  2.49  69,540 
10/11/2024 2.30  2.39  2.30  2.36  15,851 
10/10/2024 2.35  2.37  2.25  2.30  89,159 
10/09/2024 2.43  2.43  2.34  2.34  28,695 
10/08/2024 2.42  2.43  2.40  2.41  25,314 
10/07/2024 2.40  2.49  2.40  2.43  16,364 
10/04/2024 2.44  2.51  2.37  2.42  69,568 
10/03/2024 2.40  2.44  2.40  2.44  30,522 
10/02/2024 2.42  2.45  2.40  2.41  13,729 
10/01/2024 2.53  2.53  2.41  2.42  59,919 
09/30/2024 2.52  2.58  2.49  2.57  35,900 
09/27/2024 2.56  2.56  2.48  2.54  32,970 

About NervGen Pharma Stock history

NervGen Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for NervGen is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in NervGen Pharma Corp will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing NervGen Pharma stock prices may prove useful in developing a viable investing in NervGen Pharma
Last ReportedProjected for Next Year
Common Stock Shares Outstanding59.6 M41.5 M
Net Loss-18.7 M-17.7 M

NervGen Pharma Stock Technical Analysis

NervGen Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Overlap Analysis
View
Forecast Models
View
Price Shifting
View
Volatility Indicators
View
Value Movement
View
A focus of NervGen Pharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of NervGen Pharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Financial Widgets Now

   

Financial Widgets

Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
All  Next Launch Module

NervGen Pharma Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for NervGen Pharma's price direction in advance. Along with the technical and fundamental analysis of NervGen Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of NervGen to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance0.0508
Jensen Alpha0.2872
Total Risk Alpha0.1385
Sortino Ratio0.0559
Treynor Ratio0.4118
Cycle Indicators
Math Operators
Math Transform
Momentum Indicators
Overlap Studies
Pattern Recognition
Price Transform
Statistic Functions
Volatility Indicators
Volume Indicators

Additional Tools for NervGen Stock Analysis

When running NervGen Pharma's price analysis, check to measure NervGen Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NervGen Pharma is operating at the current time. Most of NervGen Pharma's value examination focuses on studying past and present price action to predict the probability of NervGen Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NervGen Pharma's price. Additionally, you may evaluate how the addition of NervGen Pharma to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY